Connection

Miguel Hernán to Aged

Back to Details
This is a "connection" page, showing publications Miguel Hernán has written about Aged.
Miguel Hernán
Connection Strength
0.104
Aged
  1. Lockdown measures and relative changes in the age-specific incidence of SARS-CoV-2 in Spain. Epidemiol Infect. 2020 10 21; 148:e268.
    View in: PubMed
    Score: 0.016
  2. The meaning of confounding adjustment in the presence of multiple versions of treatment: an application to organ transplantation. Eur J Epidemiol. 2019 Mar; 34(3):225-233.
    View in: PubMed
    Score: 0.014
  3. Electronic medical records can be used to emulate target trials of sustained treatment strategies. J Clin Epidemiol. 2018 04; 96:12-22.
    View in: PubMed
    Score: 0.014
  4. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology. 2004 Sep 14; 63(5):838-42.
    View in: PubMed
    Score: 0.005
  5. Early Convalescent Plasma Therapy and Mortality Among US Veterans Hospitalized With Nonsevere COVID-19: An Observational Analysis Emulating a Target Trial. J Infect Dis. 2021 09 17; 224(6):967-975.
    View in: PubMed
    Score: 0.004
  6. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N Engl J Med. 2021 09 16; 385(12):1078-1090.
    View in: PubMed
    Score: 0.004
  7. Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019-Related Respiratory Failure. Crit Care Med. 2021 07 01; 49(7):1026-1037.
    View in: PubMed
    Score: 0.004
  8. ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19. J Clin Epidemiol. 2021 11; 139:240-254.
    View in: PubMed
    Score: 0.004
  9. Critical Care Requirements Under Uncontrolled Transmission of SARS-CoV-2. Am J Public Health. 2021 05; 111(5):923-926.
    View in: PubMed
    Score: 0.004
  10. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021 04 15; 384(15):1412-1423.
    View in: PubMed
    Score: 0.004
  11. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19. Ann Intern Med. 2021 05; 174(5):622-632.
    View in: PubMed
    Score: 0.004
  12. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. JAMA Intern Med. 2021 01 01; 181(1):41-51.
    View in: PubMed
    Score: 0.004
  13. Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study. BMJ. 2020 11 27; 371:m4509.
    View in: PubMed
    Score: 0.004
  14. Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. JAMA Intern Med. 2020 11 01; 180(11):1436-1447.
    View in: PubMed
    Score: 0.004
  15. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020 08 22; 396(10250):535-544.
    View in: PubMed
    Score: 0.004
  16. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy : A Cohort Study. Ann Intern Med. 2020 10 06; 173(7):536-541.
    View in: PubMed
    Score: 0.004
  17. Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance. AIDS. 2018 01 28; 32(3):327-335.
    View in: PubMed
    Score: 0.003
  18. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol. 2003 Aug; 60(8):1059-64.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.